While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...
If you’ve been diagnosed with breast cancer, you’re likely wondering if it has spread and if so, how far? Your doctor can ...
A new machine-learning model can identify the stage of disease in ductal carcinoma in situ, a type of preinvasive tumor that can sometimes progress to a deadly form of breast cancer. This could help ...
The leaders of the MSK Lobular Breast Cancer program (from left), breast pathologist Fresia Pareja, MD, PhD; breast surgeon Anita Mamtani, MD; breast medical oncologist Sherry Shen, MD. The program is ...
Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...
Breast cancer may be more treatable than many other cancers, however, even their treatability depends on how early they are ...
MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...
Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.